HLB Life Science Co., Ltd. (KOSDAQ:067630)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Bio Development			425.99M	312.98M	12.68M	7.28M	210.00M
Other			4.99B	5.17B	4.55B	4.04B	3.85B
Medicare Division			30.19B	35.79B	-	-	-
Construction and Engineering			1.36B	5.89B	11.57B	14.32B	11.02B
Internal Sales			-2.39B	-1.62B	-372.94M	-1.63B	-8.91B
Pharmaceutical Distribution			63.42B	54.06B	37.73B	75.06B	107.85B
Total			97.99B	99.59B	53.49B	91.80B	114.02B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea			97.63B	99.48B	53.49B	91.80B	114.02B
Foreign Country			360.71M	107.14M	-	-	-
Total			97.99B	99.59B	53.49B	91.80B	114.02B

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 7, 2026

Data Sources Report a data error